NASDAQ · Medical - Devices

Adagio Medical Holdings, Inc (ADGM) Stock

$0.13 +0.00% NASDAQ: ADGM Healthcare

Valuation

MetricValue
Price$0.13
Market Cap$2.89M
P/E Ratio-0.09
P/B Ratio-6.96
P/S Ratio0.00
EPS (TTM)$-1.51
52-Week High$2.58
52-Week Low$0.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-661.85%
ROA-80.08%
ROCE-75.31%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-62.65
Current Ratio2.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-21.0M$-24.0M$-28.0M$-62.0M$-22.0M
Net Profit$-20.0M$-24.0M$-38.0M$-54.0M$-25.0M
EPS$-0.34$-1.23$-0.16$-3.54$-1.51
Op Margin-7646.3%-12652.4%-9314.0%-23226.8%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$21.0M$9.0M$7.0M$48.0M$43.0M
Total Liabilities$94.0M$105.0M$139.0M$29.0M$31.0M
Cash$19.0M$6.0M$1.0M$21.0M$17.0M
Borrowings$0$10.0M$38.0M$16.0M$22.0M

Latest News

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System Business Wire · Aug 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-19.0M$-22.0M$-1.0M$-29.0M$-19.0M
Investing Cash Flow$-3.0M$-1.0M$114.0M$-3.0M$-1.0M
Financing Cash Flow$0$0$-115.0M$0$0
Net Cash Flow$-20.0M$5.0M$-6.0M$21.0M$-3.0M
Free Cash Flow$-21.0M$-23.0M$-1.0M$-31.0M$-19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.91
FCF Yield-560.93%
Quick Ratio1.15
Interest Coverage-6.38
Return 1Y-60.70%
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALURAllurion Technologies Inc. $4.72 -14.27% -0.08 $4.72M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
COCHEnvoy Medical, Inc. $0.66 +0.03% -0.97 $50.78M 0.00%
CODXCo-Diagnostics, Inc. $1.12 +2.75% -0.04 $7.00M 0.00%
CTXRCitius Pharmaceuticals, Inc. $0.50 +2.19% -0.25 $13.71M 0.00%

About Adagio Medical Holdings, Inc

Adagio Medical Holdings, Inc is led by CEO Todd Usen, employs 80 people, headquartered in US, publicly traded since 2024.

Adagio Medical Holdings, Inc (ADGM) stock trades at $0.13 with a market capitalization of $2.89M. The stock is valued at a price-to-earnings (P/E) ratio of -0.09, price-to-book of -6.96, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.12 and $2.58, and currently trades 95.0% below its 52-week high.

On profitability, Adagio Medical Holdings, Inc generates a return on equity (ROE) of -661.85%, return on capital employed of -75.31%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides